Funding

Wonderlab Bio

United States · Biotech · Healthtech

Makes off-the-shelf iPSC-derived cell therapies using HLA-matched super donors for broad patient access

Visit wonderlab.bioFunding history

Funding history

1 round · 0 with disclosed amounts
AnnouncedRoundAmountInvestors
StrategicUndisclosedJetstream Venture Fund — Role not disclosed

Investors

Jetstream Venture FundStrategic

Coverage

May 14, 2026Wonderlab Bio · Strategic

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
Sourceswonderlab.bio ↗